HALO vs. ITCI
Compare and contrast key facts about Halozyme Therapeutics, Inc. (HALO) and Intra-Cellular Therapies, Inc. (ITCI).
Performance
HALO vs. ITCI - Performance Comparison
Loading graphics...
HALO vs. ITCI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
HALO Halozyme Therapeutics, Inc. | -2.82% | 40.77% | 29.36% | -35.04% | 41.51% | -5.85% | 140.89% | 21.19% | -27.79% | 105.06% |
ITCI Intra-Cellular Therapies, Inc. | 0.00% | 57.89% | 16.62% | 35.34% | 1.11% | 64.59% | -7.32% | 201.23% | -21.34% | -4.04% |
Fundamentals
HALO:
$1.40B
ITCI:
$680.64M
HALO:
$1.17B
ITCI:
$623.67M
HALO:
$590.37M
ITCI:
-$116.21M
Returns By Period
HALO
- 1D
- 1.19%
- 1M
- -6.37%
- YTD
- -2.82%
- 6M
- -12.73%
- 1Y
- 5.71%
- 3Y*
- 19.64%
- 5Y*
- 9.04%
- 10Y*
- 20.96%
ITCI
- 1D
- —
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HALO vs. ITCI — Risk / Return Rank
HALO
ITCI
HALO vs. ITCI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Halozyme Therapeutics, Inc. (HALO) and Intra-Cellular Therapies, Inc. (ITCI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HALO | ITCI | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.13 | — | — |
Sortino ratioReturn per unit of downside risk | 0.47 | — | — |
Omega ratioGain probability vs. loss probability | 1.08 | — | — |
Calmar ratioReturn relative to maximum drawdown | 0.08 | — | — |
Martin ratioReturn relative to average drawdown | 0.17 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| HALO | ITCI | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.13 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.23 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.48 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.23 | — | — |
Correlation
The correlation between HALO and ITCI is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
HALO vs. ITCI - Dividend Comparison
Neither HALO nor ITCI has paid dividends to shareholders.
Drawdowns
HALO vs. ITCI - Drawdown Comparison
Loading graphics...
Drawdown Indicators
| HALO | ITCI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -74.26% | — | — |
Max Drawdown (1Y)Largest decline over 1 year | -31.69% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -49.06% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -49.06% | — | — |
Current DrawdownCurrent decline from peak | -19.49% | — | — |
Average DrawdownAverage peak-to-trough decline | -32.02% | — | — |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.78% | — | — |
Volatility
HALO vs. ITCI - Volatility Comparison
Loading graphics...
Volatility by Period
| HALO | ITCI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.11% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 23.48% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 43.82% | — | — |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 39.51% | — | — |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 43.38% | — | — |
Financials
HALO vs. ITCI - Financials Comparison
This section allows you to compare key financial metrics between Halozyme Therapeutics, Inc. and Intra-Cellular Therapies, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities